OK EU for targeted therapy for acute myeloid leukemia and cholangiocarcinoma
The European Commission (EC) has approved ivosidenib tablets as targeted therapy in two indications: in combination ...
Read moreThe European Commission (EC) has approved ivosidenib tablets as targeted therapy in two indications: in combination ...
Read moreThe Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency EMA has ...
Read more© Ruetir 2023. All Rights Reserved.